You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 24 No. 2, February 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Chlorpromazine and Sleep in Psychiatric Patients

David J. Kupfer, MD; Richard J. Wyatt, MD; Frederick Synder, MD; John M. Davis, MD

Arch Gen Psychiatry. 1971;24(2):185-189.


Abstract

The effect of chlorpromazine on nine patients with sleep disturbance was investigated. The results showed that chlorpromazine given at bedtime coincided with a marked increase in actual sleep time as exemplified by a significant decrease in intermittent wakefulness. Total REM time was increased proportionately to the increase in actual sleep. In a more extensive study in four patients, it was found that the administration of daytime chlorpromazine (100 mg) had no direct effect on sleep as compared to placebo. In contrast, bedtime chlorpromazine was associated with significant changes in various sleep parameters. That the time course of chlorpromazine administration is responsible for the differential effect on sleep is supported by the preliminary investigation with plasma chlorpromazine levels.



Author Affiliations

Bethesda, Md

From the Laboratory of Clinical Psychobiology, Division of Clinical and Behavioral Research, National Institute of Mental Health, Bethesda, Md. Dr. Kupfer is now at the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn. Dr. Wyatt is now at the Laboratory of Clinical Psychopharmacology, Special Mental Health Division, NIMH, St. Elizabeth's Hospital, Washington, DC. Dr. Davis is now at the Laboratory of Clinical Science, CBRS, NIMH, Bethesda, Md.


Footnotes

Accepted for publication June 2, 1970.

Reprint requests to Laboratory of Clinical Psychobiology, CBRP, NIMH, Bethesda, Md 20014 (Dr. Synder).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sleep in Schizophrenic Patients On and Off Haloperidol Therapy: Clinically Stable vs Relapsed Patients
Neylan et al.
Arch Gen Psychiatry 1992;49:643-649.
ABSTRACT  

Electroencephalographic Sleep Abnormalities in Schizophrenia: Relationship to Positive/Negative Symptoms and Prior Neuroleptic Treatment
Tandon et al.
Arch Gen Psychiatry 1992;49:185-194.
ABSTRACT  

Endogenous Depression Improvement and REM Pressure
Vogel et al.
Arch Gen Psychiatry 1977;34:96-97.
ABSTRACT  

Clinical Trials and Tribulations
Morgan et al.
Arch Intern Med 1974;134:380-383.
ABSTRACT  

Effect of Prolonged Chlorpromazine Administration on the Sleep of Chronic Schizophrenics
Kaplan et al.
Arch Gen Psychiatry 1974;31:62-66.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.